BDSX
Biodesix, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$26.18
−1.11%Aug 5, 2026, 20:01 UTC
Biodesix reported second quarter 2026 revenue of $26.9 million, a 34% increase year over year, with an 82% gross margin, and maintained its full-year 2026 revenue guidance of $108-114 million.